Orexo AB (publ)

kr 1.37As of Sun 8 Nov 2026, 12:00 UTC
STO:ORXHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (29.60%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.03
PE TTM 0.121
TSR TTM (95.08%)
Mkt cap kr 47.77M
ROIC (1171.66%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.66
21.32%
(31.56%)
Buy 10|12|11|2|1
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.01
0.01
0.01
0.01
(9.94%)
0.37%
(2.14%)
0.69%
Revenuekr M
3.129
3.091
3.040
3.022
11.58%
8.00%
2.81%
(1.66%)
Peers (US$4.830M)
Cap (US$)
PE
7.846M
—
Capital
TTM
5Y
10Y
Leveragex
3.671
0.035
0.034
EBIT/Intx
1.466
0.048
0.061
Own earn%
338.19
(68.85)
(74.65)
Sh yield%
24.46
25.27
30.76
Owners
Insiders/Inst%
10.41
57.51
Short interest%
1.27
SBC / revenue%
3.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
21–33
$1 testx
−0.5
Incr. ROIC%
6